Shreyas N B Bio Investigatory Project
Shreyas N B Bio Investigatory Project
Shreyas N B Bio Investigatory Project
VIDYALAYA
TOPIC : MALARIA
SUBMITTED BY :
SHREYAS N B
12th A GUIDED BY :
SMT PADMA B V
[PGT BIOLOGY]
CERTIFICATE
PRINCIPAL
ACKNOWLEDGEMENT
Sub-Saharan Africa
South and Southeast Asia
Pacific Islands
Central America and northern South America
PREVENTION
If you live in or are traveling to an area where malaria is
common, take steps to avoid mosquito bites. Mosquitoes
are most active between dusk and dawn. To protect yourself
from mosquito bites, you should:
Cover your skin. Wear pants and long-sleeved shirts. Tuck in
your shirt, and tuck pant legs into socks.
Apply insect repellent to skin. Use an insect repellent
registered with the Environmental Protection Agency on
any exposed skin. These include repellents
that contain DEET, picaridin, IR3535,
oil of lemon eucalyptus (OLE), para-menthane-3,8-diol (PMD) or
2-undecanone. Do not use a spray
directly on your face. Do not use products with OLE
or PMD on children under age 3.
Apply repellent to clothing. Sprays containing permethrin are
safe to apply to clothing.
Sleep under a net. Bed nets, particularly those treated with
insecticides, such as permethrin, help prevent mosquito bites
while you are sleeping.
PREVENTIVE MEDICINE
If you'll be traveling to a location where malaria is common, talk
to your doctor a few months ahead of time about whether you
should take drugs before, during and after your trip to help
protect you from malaria parasites.
In general, the drugs taken to prevent malaria are the same
drugs used to treat the disease. What drug you take depends
on where and how long you are traveling and your own health.
TREATMENT
Malaria is treated with antimalarial medications; the ones used
depends on the type and severity of the disease. While
medications against fever are commonly used, their effects on
outcomes are not clear. Simple or uncomplicated malaria may be
treated with oral medications. The most effective treatment for
P. falciparum infection is the use of artemisinins in combination
with other antimalarials (known as artemisinin-combination
therapy, or ACT), which decreases resistance to any single drug
component.These additional antimalarials include: amodiaquine,
lumefantrine, mefloquine or sulfadoxine/pyrimethamine.[94]
Another recommended combination is dihydroartemisinin and
piperaquine. ACT is about 90% effective when used to treat
uncomplicated malaria. To treat malaria during pregnancy, the
WHO recommends the use of quinine plus clindamycin early in
the pregnancy (1st trimester), and ACT in later stages (2nd and
3rd trimesters). In the 2000s (decade), malaria with partial
resistance to artemisins emerged in Southeast Asia. Infection
with P. vivax, P. ovale or P. malariae usually do not require
hospitalization. Treatment of P. vivax requires both treatment of
blood stages (with chloroquine or ACT) and clearance of liver
forms with primaquine. Treatment with tafenoquine prevents
relapses after confirmed P. vivax malaria.
Severe and complicated malaria are almost always caused by
infection with P. falciparum. The other species usually cause
only febrile disease.
Severe and complicated malaria are almost
always caused by infection with P. falciparum.
The other species usually cause only febrile
disease. Severe and complicated malaria are medical
emergencies since mortality rates are high (10% to 50%).
Cerebral malaria is the form of severe and complicated malaria
with the worst neurological symptoms. Recommended
treatment for severe malaria is the intravenous use of
antimalarial drugs. For severe malaria, parenteral artesunate
was superior to quinine in both children and adults. In another
systematic review, artemisinin derivatives (artemether and
arteether) were as efficacious as quinine in the treatment of
cerebral malaria in children. Treatment of severe malaria
involves supportive measures that are best done in a critical
care unit. This includes the management of high fevers and
the seizures that may result from it. It also includes monitoring
for poor
breathing effort, low blood sugar, and low blood potassium.
Conclusion
Malaria is an enormous global disease burden, and its
eradication is an ambitious goal.
The disease, caused by mosquito-borne parasites, is present in
102 countries and is responsible for over 100 million clinical
cases and 1 to 2 million deaths each year. Over the past two
decades, efforts to control malaria have met withless and less
success.
BIBLIOGRAPHY
https://www.mayoclinic.org/diseases-conditions/malaria/symptoms-
causes/syc-20351184